COMPANYTeam

CEO

Kimihiko Sato

Kimihiko joined bitBiome in February 2020 as COO and assumed his current role in April 2021. Leveraging his expertise in business strategy and biology, he is leading the entire bitBiome team in setting our overall direction.
Previously, he worked as a project leader at Boston Consulting Group (BCG) for seven years focusing on the healthcare sector. At BCG, He advised multiple global and Japanese pharmaceutical companies and fermentation companies and helped them develop and implement such as mid/long-term corporate growth strategy, new product launch, sales, and manufacturing. Prior to BCG, he also worked at Mitsui Sumitomo Insurance Company, in the product development department working on actuarial science.
He holds a M.S. in molecular biology at the University of Tokyo.

Founder/Director, CSO (Chief Scientific Officer)

Masahito Hosokawa, Ph.D.

Masahito Hosokawa is a founder and CSO of bitBiome. He also has a position as an associate professor at Waseda University. He has over 8 years of research experience in development and application of novel microfluidic tools for single-cell genomics and transcriptomics. Based on this single-cell genomics platform, he founded bitBiome in 2018.
Previously, he worked at Shizuoka Cancer Center between 2011 and 2013, and then moved to Waseda University in 2013 and started single-cell research as a JST-PRESTO researcher in 2015.
His awards include The Young Scientists’ Prize by the Minister of Education, Culture, Sports, Science and Technology (2019) and the JST PRESTO Innovation Award (2019). He holds a Ph.D. in Engineering from Tokyo University of Agriculture and Technology.

Director, COO

Yuji Suzuki

Yuji Suzuki joined bitBiome as COO in October 2021 and assumed his current role in April 2022. He has an extensive experience in strategy, business development and operational transformation.
Previously he served as executive vice president in Human Metabolome Technologies and engagement manager in McKinsey & Company, leading and advising growth companies. He has also held senior positions at Rakuten Group, Inc. and Macromill, Bain Capital portfolio company.
He holds an MPhil in Oriental Studies from the University of Cambridge and a BA in International Relations from the University of Tokyo.

External Director

Atsushi Usami, Ph.D.

Atsushi Usami is a Partner and Board Director at UTEC, focusing on seed/early-stage life science investments. He currently serves on the boards of Repertoire Genesis Inc., Goryo Chemical Inc., EditForce Inc., MiRTel Co. Ltd., Epigeneron Inc., Bugworks Research inc., bitBiome Inc., OriCiro Genomics, Inc and others.
Prior to joining UTEC in October 2013, he worked as a strategy consultant at Mitsubishi Research Institute, serving pharmaceutical, medical device and other manufacturing companies across a range of areas including mid-to-long term management planning and new business development.
In 2012, he received a Ph.D. in pharmaceutical sciences from the University of Tokyo. He provides support for Life Science Innovation Network Japan (LINK-J). Auditor.

Auditor

Noriaki Sakamoto

Nori Sakamoto is a Partner and Board Director at UTEC, focusing on high growth seed/early stage life science and IT fields. He currently serves as an external director of ZenmuTech Co., Ltd., Finatext Corporation, Institution for a Global Society Co., Ltd., Retriever Co., Ltd and others.
Prior to joining UTEC in August 2014, he worked at McKinsey and Company for 4 years. Prior to McKinsey, he worked in his family business as a president for 1.5 year and then for the Ministry of Economy, Trade and Industry (METI) for 5 years.
He graduated from the University of Tokyo’s Faculty of Economy, earned his MBA from Columbia Business School. He was a co-translator of “Valuation: Measuring and Managing the Value of Companies” at McKinsey.

Head of Technology

Soichiro Tsuda, Ph.D.

Soichiro Tsuda joined bitBiome in October, 2020. He has expertise in interdisciplinary research across biology, engineering, and mathematical modelling. At bitBiome, he is leading new application developments using microbial single cell genome sequencing technology and massive microbial genomic database.
Previously, he worked as a Lord Kelvin-Adam Smith Research Fellow at the University of Glasgow, UK (2012), a JSPS Research Fellow (2019), and the General Manager of Application Development at On-Chip Biotechnologies, Co. Ltd.
He holds a Ph.D. in Biology at Kobe University in 2007.